<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">120751</article-id><article-id pub-id-type="doi">10.23868/201811038</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Angiogenic properties of myocardial c-kit+ cells</article-title><trans-title-group xml:lang="ru"><trans-title>Характеристика ангиогенных свойств c-kit+-клеток миокарда</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dergilev</surname><given-names>K. V</given-names></name><name xml:lang="ru"><surname>Дергилев</surname><given-names>К. В</given-names></name></name-alternatives><email>doctorkote@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tsokolaeva</surname><given-names>Z. I</given-names></name><name xml:lang="ru"><surname>Цоколаева</surname><given-names>З. И</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Beloglazova</surname><given-names>I. B</given-names></name><name xml:lang="ru"><surname>Белоглазова</surname><given-names>И. Б</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ratner</surname><given-names>E. I</given-names></name><name xml:lang="ru"><surname>Ратнер</surname><given-names>Е. И</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Molokotina</surname><given-names>Yu. D</given-names></name><name xml:lang="ru"><surname>Молокотина</surname><given-names>ЮД. D</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Parfenova</surname><given-names>E. V</given-names></name><name xml:lang="ru"><surname>Парфенова</surname><given-names>Е. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Experimental Cardiology, National Medical Research Center of Cardiology</institution></aff><aff><institution xml:lang="ru">Институт экспериментальной кардиологии Национального медицинского исследовательского центра кардиологии</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">M.V. Lomonosov Moscow State University</institution></aff><aff><institution xml:lang="ru">Московский государственный университет им. М.В. Ломоносова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2018</year></pub-date><volume>13</volume><issue>3</issue><issue-title xml:lang="en">VOL 13, NO3 (2018)</issue-title><issue-title xml:lang="ru">ТОМ 13, №3 (2018)</issue-title><fpage>82</fpage><lpage>88</lpage><history><date date-type="received" iso-8601-date="2023-01-05"><day>05</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Эко-Вектор</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/120751">https://genescells.ru/2313-1829/article/view/120751</self-uri><abstract xml:lang="en"><p>Now, great interest is connected with application of the cells received directly from a myocardium as the tool for stimulation of angiogenesis and reparative processes in heart. The aim of the present research is studying of angiogenic properties in vitro and in vivo of c-kit+-cells, obtained from hearts of small rodents. The work was performed on male C57BL/6 mice and male Wistar rats. The study used methods of cytofluorimetry, immuno-fluorescent staining, models of myocardial infarction and subcutaneous angiogenesis in Matrigel™. It was shown, that after acute myocardial infarction c-kit+ cells activated, part of which entered into endothelial differentiation and integrated into de novo formed vessels. C-kit+-expressed the markers of vascular progenitor cells, exhibited endothelial-like behavior in vitro, and after subcutaneous transplantation increased vascularization of Matrigel™. This is achieved both due to the paracrine effects, which stimulate the growth of the recipient's mouse vessels into the Matrigel implant, and partially due to the differentiation of the transplanted cells into the vascular endothelium cells, which was confirmed by vital dye staining. Thus, c-kit+-cells derived from the myocardium can be considered as a promising type of resident cells exhibiting the properties of progenitor cells of the heart vessels for developing approaches to stimulate vascularization of the ischemic myocardium.</p></abstract><trans-abstract xml:lang="ru"><p>В настоящее время большой интерес вызывает возможность использования клеток, получаемых непосредственно из миокарда, в качестве инструмента для стимуляции ангиогенеза и репаративных процессов в сердце. Целью данного исследования было изучение in vitro и in vivo ангиогенных свойств c-kit+-кпеток, получаемых из миокарда мелких грызунов. Работа выполнена на самцах мышей линии C57BL/6 и крыс линии Вистар. В исследовании использованы методы проточной цитофлуориметрии, иммунофлуоресцентного анализа, модели инфаркта миокарда и подкожного ангиогенеза в Матригеле™. Было показано, что после острого инфаркта миокарда происходит значительная активация пула с-kit-клеток, часть из которых вступают в эндотелиальную дифференцировку и интегрируются в сосуды, образующиеся de novo. Культивированные in vitro с-№-клетки экспрессируют маркеры сосудистых клеток-предшественниц, проявляют эндотелиоподобные свойства, а после подкожной трансплантации в организм мыши в Матригеле™ вызывают значительное повышение васкуляризации трансплантата. Это достигается как за счет паракринных эффектов, стимулирующих прорастание сосудов мыши-реципиента в Матригель, так и частично за счет дифференцировки трансплантированных клеток в клетки эндотелия сосудов, что подтверждено при использовании клеток, прижизненно меченных витальным красителем. Таким образом, с-kit-клетки, получаемые из миокарда, могут рассматриваться как перспективный тип резидентных клеток, проявляющих свойства прогениторных клеток сосудов сердца, для разработки подходов к стимуляции васкуляризации ишемизированного миокарда.</p></trans-abstract><kwd-group xml:lang="en"><kwd>c-kit+-cells</kwd><kwd>cardiac progenitor cells</kwd><kwd>myocardial infarction</kwd><kwd>vascularization</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>с-kit-клетки</kwd><kwd>прогениторные клетки сердца</kwd><kwd>инфаркт миокарда</kwd><kwd>васкуляризация</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Michler R.E. The current status of stem cell therapy in ischemic heart disease. J. Card. Surg. 2018; 33(9): 520-31.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Litwinowicz R., Kapelak B., Sadowski J. et al. The use of stem cells in ischemic heart disease treatment. Kardiochir. Torakochirurgia. Pol. 2018; 15(3): 196-9.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lalu M.M., Mazzarello S., Zlepnig J. et al. Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (SafeCell Heart): a systematic review and meta-analysis. Stem Cells Transl. Med. 2018; 9999: 1-10.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bolli R., Chugh A.R., D'Amario D. et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011; 378(9806): 1847-57.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Dergilev K.V., Rubina K.A., Tsokolaeva Z.I. et al. Left ventricular heart aneurism - a new source of resident cardiac stem cells. Tsitologiia 2010; 52(11): 921-30.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Broughton K.M., Wang B.J., Firouzi F. et al. Mechanisms of Cardiac Repair and Regeneration. Circ. Res. 2018; 122(8): 1151-63.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Dergilev K.V., Rubina K.A., Parfenova E.V. Resident cardiac stem cells. Kardiologiia 2011; 51(4): 84-92.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Menasché P. Cell therapy trials for heart regeneration - lessons learned and future directions. Nat. Rev. Cardiol. 2018; 15(11): 659-71.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Senyo S.E., Steinhauser M.L., Pizzimenti C.L. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013; 493(7432): 433-6.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Cahill T.J., Choudhury R.P., Riley P.R. Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics. Nature Reviews Drug Discovery 2017; 16: 699-717.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ovsepyan A.A., Panchenkov D.N., Prokhortchouk E.B. et al. Modeling myocardial infarction in mice: methodology, monitoring, pathomorphology. Acta Naturae 2011; 3(1): 107-15.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Traktuev D.O., Tsokolaeva Z.I., Shevelev A.A. et al. Urokinase gene</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>transfer augments angiogenesis in ischemic skeletal and myocardial muscle. Mol. Ther. 2007; 15(11): 1939-46.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Dergilev K.V., Makarevich P.I., Tsokolaeva Z.I. et al. Comparison of cardiac stem cell sheets detached by Versene solution and from thermo-responsive dishes reveals similar properties of constructs. Tissue and Cell 2017; 49(1): 64-71.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Salikova S.P., Bakhtiiarov R.Z. The role of structural changes of the endothelium and myocardium in the development of experimental heart failure. Morfologiia 2008; 134(5): 20-5.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Torsney E., Xu Q. Resident vascular progenitor cells. J. Mol. Cell. Cardiol. 2011; 50(2): 304-11.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Leri A., Rota M., Hosoda T. et al. Cardiac stem cell niches. Stem Cell Res. 2014; 13(3): 631-46.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Gambini E., Pompilio G., Biondi A. et al. C-kit+ cardiac progenitors exhibit mesenchymal markers and preferential cardiovascular commitment. Cardiovasc. Res. 2011; 89(2): 362-73.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Broughton K.M., Wang B.J., Firouzi F. et al. Mechanisms of Cardiac Repair and Regeneration. Circ. Res. 2018; 122(8): 1151-63.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kobayashi K., Maeda K., Takefuji M. et al. Dynamics of angiogenesis in ischemic areas of the infarcted heart. Sci. Rep. 2017; 7(1): 7156.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>He L., Huang X., Kanisicak O. et al. Preexisting endothelial cells mediate cardiac neovascularization after injury. J. Clin. Invest. 2017; 127(8): 2968-81.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Li Y., He L., Huang X. et al. Genetic Lineage Tracing of Non-Myocyte Population by Dual Recombinases. Circulation 2018; 138(8): 793-805.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Tillmanns J., Rota M., Hosoda T. et al. Formation of large coronary arteries by cardiac progenitor cells. PNAS USA 2008; 105(5): 1668-73.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Bearzi C., Leri A., Lo Monaco F. et al. Identification of a coronary vascular progenitor cell in the human heart. PNAS USA 2009; 106(37): 15885-90.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Chen Z., Zhu W., Bender I. et al. Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells. Circulation 2017; 136(24): 2359-72.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Laurenzana A., Fibbi G., Margheri F. et al. Endothelial Progenitor Cells in Sprouting Angiogenesis: Proteases Pave the Way. Curr. Mol. Med. 2015; 15(7): 606-20.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Tkachuk V.A., Plekhanova O.S., Parfyonova Y.V. Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. Can. J. Physiol. Pharmacol. 2009; 87(4): 231-51.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Loscalzo J. The macrophage and fibrinolysis. Semin. Thromb. Hemost. 1996; 22(6): 503-6.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Stepanova V.V., Tkachuk V.A. Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc.) 2002; 67(1): 109-18.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Parfenova E.V., Plekhanova V.V., Stepanova V.V. et al. Plasminogen activator of urokinase-type: mechanisms of involvement in vessel remodeling and angiogenesis, gene therapy approaches to ischemia. Ross. Fiziol. Zh. Im. I.M. Sechenova. 2004; 90(5): 547-68.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Wu B., Zhang Z., Lui W. et al. Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell 2012; 151(5): 1083-96.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Jin Z.G., Ueba H., Tanimoto T. et al. Ligand independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ. Res. 2003; 93: 354-63.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Дергилев К.В., Цоколаева З.И., Белоглазова И.Б. и др. Интрамио-кардиальное введение c-kit+-прогениторных клеток сердца вызывает активацию прогениторных клеток эпикарда и стимулирует васкуляризацию после инфаркта. Гены и Клетки 2018; 13(1): 75-81.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Chimenti I., Smith R.R., Li T.S. et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ. Res. 2010; 106: 971-80.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Bianconi V., Sahebkar A., Kovanen P. et al. Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy. Pharmacol. Ther. 2018; 181: 156-68.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Barile L., Lionetti V., Cervio E. et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc. Res. 2014; 103(4): 530-41.</mixed-citation></ref></ref-list></back></article>
